Georgia GarinoisMelenikiotou - Inspire Medical Director
| 2DR Stock | EUR 180.25 2.10 1.15% |
Insider
Georgia GarinoisMelenikiotou is Director of Inspire Medical Systems since 2020.
| Tenure | 5 years |
| Phone | 844 672 4357 |
| Web | https://www.inspiresleep.com |
Inspire Medical Management Efficiency
The company has return on total asset (ROA) of (0.0692) % which means that it has lost $0.0692 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1238) %, meaning that it generated substantial loss on money invested by shareholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Pedro Gutirrez | Aedas Homes SA | 53 | |
| Coro Morales | Aedas Homes SA | N/A | |
| Diane Kumarich | Addus HomeCare | N/A | |
| Joanne Halliday | American Homes 4 | N/A | |
| Catherine Ward | Corporate Office Properties | N/A | |
| Bradley Bickham | Addus HomeCare | 60 | |
| Greg Jansen | Perdoceo Education | 48 | |
| Deborah Snyder | Perdoceo Education | N/A | |
| David Czeszewski | Perdoceo Education | 59 | |
| Alfonso Grases | Aedas Homes SA | N/A | |
| John Kline | Perdoceo Education | 60 | |
| David CPA | American Homes 4 | 62 | |
| Sergio Galvez | Aedas Homes SA | N/A | |
| Megan Grabos | American Homes 4 | N/A | |
| Milagros Urena | Aedas Homes SA | 58 | |
| Zach Simpson | Addus HomeCare | N/A | |
| Esther Duarte | Aedas Homes SA | N/A | |
| Gregory Thor | Corporate Office Properties | 59 | |
| Andrew Hurst | Perdoceo Education | 60 | |
| Esther Macarro | Aedas Homes SA | 50 | |
| David Finch | Corporate Office Properties | N/A | |
Management Performance
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0692 |
Inspire Medical Systems Leadership Team
Elected by the shareholders, the Inspire Medical's board of directors comprises two types of representatives: Inspire Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspire. The board's role is to monitor Inspire Medical's management team and ensure that shareholders' interests are well served. Inspire Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspire Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Georgia GarinoisMelenikiotou, Director | ||
| Timothy Herbert, President, Chief Executive Officer, Director | ||
| Philip Ebeling, Chief Operating Officer | ||
| Steven Jandrich, Chief Compliance Officer, Vice President of Human Resources | ||
| Andreas Henke, VP Europe | ||
| Casey Tansey, Independent Director | ||
| Richard Buchholz, Chief Financial Officer | ||
| Mudit Jain, Independent Director | ||
| Chau Khuong, Independent Director | ||
| Martin Abrams, VP Experience | ||
| Gary Ellis, Independent Director | ||
| John Rondoni, Chief Officer | ||
| Shawn McCormick, Independent Director | ||
| Randall Ban, Chief Commercial Officer | ||
| Dana Mead, Independent Director | ||
| Shelley Broader, Director | ||
| Ivan Lubogo, Sr Sales | ||
| Marilyn Nelson, Independent Chairman of the Board | ||
| Jerry Griffin, Independent Director | ||
| Bryan Phillips, Senior Vice President Chief Compliance Officer, General Counsel, Company Secretary |
Inspire Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspire Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0692 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.12) % | |||
| Current Valuation | 6.62 B | |||
| Shares Outstanding | 29.05 M | |||
| Shares Owned By Insiders | 2.15 % | |||
| Shares Owned By Institutions | 99.46 % | |||
| Price To Book | 15.49 X | |||
| Price To Sales | 19.86 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Inspire Stock
When determining whether Inspire Medical Systems is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Inspire Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Inspire Medical Systems Stock. Highlighted below are key reports to facilitate an investment decision about Inspire Medical Systems Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.